COVID-19 Resource Center for Infectious Disease Clinicians

Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 16, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID prevention and treatment in special populations and patients with certain comorbidities.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 8, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 symptoms and clinical manifestations.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 9, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on treatments for COVID-19, including authorized and investigational agents.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 10, 2022

Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 variants and vaccinations for COVID-19, including authorized and investigational agents.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: August 8, 2022

In this module, expert faculty answer healthcare professionals’ questions about COVID-19 prevention, screening, diagnosis, disease management, and treatment. New questions will be added and responses will be further developed as more data emerge.

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: June 1, 2022

Hear expert insights on why extra doses and boosters of the SARS-CoV-2 vaccines are recommended for certain populations, and learn recommendations regarding mixing and matching booster doses.

Renslow Sherer, MD Released: December 8, 2021

Hear expert insights on the rationale for the use of monoclonal antibodies for postexposure prophylaxis in high-risk populations.

Arthur Kim, MD Released: December 15, 2021

Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: January 6, 2022

Hear expert insights on a stepwise approach to evaluate treatment candidacy for oral antiviral agents for COVID-19 and practical considerations for their use.

Kristen Marks, MD Released: February 3, 2022

Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.

Arthur Kim, MD Released: February 21, 2022

Get expert insights on the symptoms, causes, risk factors, timeline, and treatment considerations for long COVID, or postacute sequelae of COVID-19 infection.

Renslow Sherer, MD Released: March 30, 2022

Hear expert insights on the latest data on and recommendations for second booster doses of COVID-19 vaccine. Learn which patients are eligible, which vaccines to administer, and timing of administration.

Kristen Marks, MD Released: May 20, 2022

Hear expert insights on the role of remdesivir for the treatment of nonhospitalized adult and pediatric patients with COVID-19.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Hear expert insights on ivermectin as a treatment for COVID-19 and evolving information on monoclonal antibodies during the latest omicron wave.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Hear expert insights on the latest data and updates regarding COVID-19 vaccines, including fourth doses, CDC recommendations, the availability of a new, non-mRNA vaccine, and authorization for our youngest pediatric patients.

Renslow Sherer, MD Released: August 1, 2022

Hear expert insights on oral antiviral efficacy in real-world populations and COVID-19 rebound phenomenon.

Arthur Kim, MD Released: August 5, 2022

The ever-evolving COVID-19 vaccination landscape has created many questions about who should receive additional vaccine doses, when, and why. Hear expert faculty discuss COVID-19 vaccination efficacy, the rationale for third doses and booster doses, and the data behind mixing and matching of booster doses.

Renslow Sherer, MD Released: December 10, 2021

Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19.

Renslow Sherer, MD Released: January 6, 2022

Do COVID-19 treatments retain their efficacy against the SARS-CoV-2 omicron variant? Hear expert faculty discuss the use of direct-acting, small-molecule antiviral agents and monoclonal antibodies during the omicron era.

Arthur Kim, MD Released: January 25, 2022

Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: February 22, 2022

Long COVID is a syndrome that can occur in some patients following their COVID-19 infection. Hear expert faculty discuss what is known to date about long COVID, including potential causes, risk factors, signs and symptoms, and treatment strategies under consideration.

Renslow Sherer, MD Released: April 13, 2022

New data have emerged regarding treatment principles and therapeutic options for nonhospitalized adult and pediatric patients with COVID-19. Hear a faculty expert describe treatment options and treatments to avoid.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: May 24, 2022